Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1047Neoplasms 821Carcinoma, Non-Small-Cell Lung 806Prostatic Neoplasms 628Colorectal Neoplasms 536Lung Neoplasms 489Neoplasm Metastasis 439Multiple Myeloma 399Leukemia, Myeloid, Acute 392Ovarian Neoplasms 336Pancreatic Neoplasms 318Melanoma 300Squamous Cell Carcinoma of Head and Neck 269Recurrence 260Carcinoma, Hepatocellular 251Glioblastoma 241Brain Neoplasms 240Triple Negative Breast Neoplasms 214Head and Neck Neoplasms 211Carcinoma, Renal Cell 211Precursor Cell Lymphoblastic Leukemia-Lymphoma 205Lymphoma 203Stomach Neoplasms 200Endometrial Neoplasms 191Uterine Cervical Neoplasms 185Glioma 184Sarcoma 183Lymphoma, Non-Hodgkin 183Lymphoma, Large B-Cell, Diffuse 168Hematologic Neoplasms 165

Interventions

Multiparametric Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urothelial Bladder Cancer × 90 days × Clear all
NCT06335667 2026-05-04

mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

University of California, Irvine

Phase NA Recruiting
30 enrolled
Genitourinary

Urothelial Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡